Literature DB >> 23553852

Measuring mitochondrial metabolism in rat brain in vivo using MR Spectroscopy of hyperpolarized [2-¹³C]pyruvate.

Jae Mo Park1, Sonal Josan, Thomas Grafendorfer, Yi-Fen Yen, Ralph E Hurd, Daniel M Spielman, Dirk Mayer.   

Abstract

Hyperpolarized [1-(13) C]pyruvate ([1-(13) C]Pyr) has been used to assess metabolism in healthy and diseased states, focusing on the downstream labeling of lactate (Lac), bicarbonate and alanine. Although hyperpolarized [2-(13) C]Pyr, which retains the labeled carbon when Pyr is converted to acetyl-coenzyme A, has been used successfully to assess mitochondrial metabolism in the heart, the application of [2-(13) C]Pyr in the study of brain metabolism has been limited to date, with Lac being the only downstream metabolic product reported previously. In this study, single-time-point chemical shift imaging data were acquired from rat brain in vivo. [5-(13) C]Glutamate, [1-(13) C]acetylcarnitine and [1-(13) C]citrate were detected in addition to resonances from [2-(13) C]Pyr and [2-(13) C]Lac. Brain metabolism was further investigated by infusing dichloroacetate, which upregulates Pyr flux to acetyl-coenzyme A. After dichloroacetate administration, a 40% increase in [5-(13) C]glutamate from 0.014 ± 0.004 to 0.020 ± 0.006 (p = 0.02), primarily from brain, and a trend to higher citrate (0.002 ± 0.001 to 0.004 ± 0.002) were detected, whereas [1-(13) C]acetylcarnitine was increased in peripheral tissues. This study demonstrates, for the first time, that hyperpolarized [2-(13) C]Pyr can be used for the in vivo investigation of mitochondrial function and tricarboxylic acid cycle metabolism in brain.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRS; brain; dichloroacetate; glutamate; hyperpolarized 13C; pyruvate; tricarboxylic acid cycle metabolism

Mesh:

Substances:

Year:  2013        PMID: 23553852      PMCID: PMC3726546          DOI: 10.1002/nbm.2935

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  42 in total

1.  Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy.

Authors:  Marie A Schroeder; Helen J Atherton; Daniel R Ball; Mark A Cole; Lisa C Heather; Julian L Griffin; Kieran Clarke; George K Radda; Damian J Tyler
Journal:  FASEB J       Date:  2009-03-27       Impact factor: 5.191

2.  Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate.

Authors:  Y-F Yen; S J Kohler; A P Chen; J Tropp; R Bok; J Wolber; M J Albers; K A Gram; M L Zierhut; I Park; V Zhang; S Hu; S J Nelson; D B Vigneron; J Kurhanewicz; H A A M Dirven; R E Hurd
Journal:  Magn Reson Med       Date:  2009-07       Impact factor: 4.668

3.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.

Authors:  Mark J Albers; Robert Bok; Albert P Chen; Charles H Cunningham; Matt L Zierhut; Vickie Yi Zhang; Susan J Kohler; James Tropp; Ralph E Hurd; Yi-Fen Yen; Sarah J Nelson; Daniel B Vigneron; John Kurhanewicz
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

4.  A 140 GHz prepolarizer for dissolution dynamic nuclear polarization.

Authors:  S Jannin; A Comment; F Kurdzesau; J A Konter; P Hautle; B van den Brandt; J J van der Klink
Journal:  J Chem Phys       Date:  2008-06-28       Impact factor: 3.488

Review 5.  Neurometabolism in human epilepsy.

Authors:  Jullie W Pan; Anne Williamson; Idil Cavus; Hoby P Hetherington; Hitten Zaveri; Ognen A C Petroff; Dennis D Spencer
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

6.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

Review 7.  MR spectroscopy in multiple sclerosis.

Authors:  Nicola De Stefano; Massimo Filippi
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

8.  Dynamic Nuclear Polarization of [1-13C]pyruvic acid at 4.6 tesla.

Authors:  Haukur Jóhannesson; Sven Macholl; Jan Henrik Ardenkjaer-Larsen
Journal:  J Magn Reson       Date:  2008-12-24       Impact factor: 2.229

Review 9.  Acylcarnitines: role in brain.

Authors:  Lauren L Jones; David A McDonald; Peggy R Borum
Journal:  Prog Lipid Res       Date:  2009-08-29       Impact factor: 16.195

Review 10.  Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.

Authors:  E D Michelakis; L Webster; J R Mackey
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more
  31 in total

Review 1.  Imaging Brain Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Lydia M Le Page; Caroline Guglielmetti; Celine Taglang; Myriam M Chaumeil
Journal:  Trends Neurosci       Date:  2020-04-08       Impact factor: 13.837

2.  IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.

Authors:  Jose L Izquierdo-Garcia; Pavithra Viswanath; Pia Eriksson; Larry Cai; Marina Radoul; Myriam M Chaumeil; Michael Blough; H Artee Luchman; Samuel Weiss; J Gregory Cairncross; Joanna J Phillips; Russell O Pieper; Sabrina M Ronen
Journal:  Cancer Res       Date:  2015-06-04       Impact factor: 12.701

Review 3.  The Astrocyte: Powerhouse and Recycling Center.

Authors:  Bruno Weber; L Felipe Barros
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-02-13       Impact factor: 10.005

Review 4.  The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.

Authors:  Sarmad Siddiqui; Stephen Kadlecek; Mehrdad Pourfathi; Yi Xin; William Mannherz; Hooman Hamedani; Nicholas Drachman; Kai Ruppert; Justin Clapp; Rahim Rizi
Journal:  Adv Drug Deliv Rev       Date:  2016-09-04       Impact factor: 15.470

Review 5.  Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Authors:  Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Kyrre E Emblem; Ovidiu Andronesi; Bruce Rosen
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

6.  Volumetric spiral chemical shift imaging of hyperpolarized [2-(13) c]pyruvate in a rat c6 glioma model.

Authors:  Jae Mo Park; Sonal Josan; Taichang Jang; Milton Merchant; Ron Watkins; Ralph E Hurd; Lawrence D Recht; Dirk Mayer; Daniel M Spielman
Journal:  Magn Reson Med       Date:  2015-05-06       Impact factor: 4.668

Review 7.  A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.

Authors:  Zachary Corbin; Daniel Spielman; Lawrence Recht
Journal:  Curr Oncol Rep       Date:  2017-11-02       Impact factor: 5.075

Review 8.  Hyperpolarized 13C MRI: State of the Art and Future Directions.

Authors:  Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron
Journal:  Radiology       Date:  2019-03-05       Impact factor: 11.105

9.  Hyperpolarized [1,4-(13)C]-diethylsuccinate: a potential DNP substrate for in vivo metabolic imaging.

Authors:  Kelvin L Billingsley; Sonal Josan; Jae Mo Park; Sui Seng Tee; Eleanor Spielman-Sun; Ralph Hurd; Dirk Mayer; Daniel Spielman
Journal:  NMR Biomed       Date:  2014-01-13       Impact factor: 4.044

10.  Hyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.

Authors:  Jae Mo Park; Daniel M Spielman; Sonal Josan; Taichang Jang; Milton Merchant; Ralph E Hurd; Dirk Mayer; Lawrence D Recht
Journal:  NMR Biomed       Date:  2016-03-14       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.